X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare J.B.Chemicals with Cipla - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs CIPLA - Comparison Results

J.B.CHEMICALS    Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

CIPLA 
   Change

Cipla is one of the largest pharma companies in the domestic market and has presence in formulations and bulk drugs manufacturing. All the bulk drug manufacturing facilities of the company have been approved by various authorities including the US FD... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS CIPLA J.B.CHEMICALS/
CIPLA
 
P/E (TTM) x 13.1 38.3 34.3% View Chart
P/BV x 2.1 3.9 52.7% View Chart
Dividend Yield % 0.2 0.3 57.3%  

Financials

 J.B.CHEMICALS   CIPLA
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-16
CIPLA
Mar-17
J.B.CHEMICALS/
CIPLA
5-Yr Chart
Click to enlarge
High Rs318622 51.1%   
Low Rs200458 43.5%   
Sales per share (Unadj.) Rs148.0181.9 81.4%  
Earnings per share (Unadj.) Rs19.112.9 148.3%  
Cash flow per share (Unadj.) Rs23.929.3 81.7%  
Dividends per share (Unadj.) Rs0.502.00 25.0%  
Dividend yield (eoy) %0.20.4 52.2%  
Book value per share (Unadj.) Rs128.9155.7 82.8%  
Shares outstanding (eoy) m84.82804.51 10.5%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x1.73.0 58.9%   
Avg P/E ratio x13.642.0 32.3%  
P/CF ratio (eoy) x10.818.4 58.7%  
Price / Book Value ratio x2.03.5 57.9%  
Dividend payout %2.615.5 16.9%   
Avg Mkt Cap Rs m21,951434,516 5.1%   
No. of employees `0002.723.0 11.9%   
Total wages/salary Rs m1,84126,338 7.0%   
Avg. sales/employee Rs Th4,590.96,349.1 72.3%   
Avg. wages/employee Rs Th673.41,143.0 58.9%   
Avg. net profit/employee Rs Th592.1449.3 131.8%   
INCOME DATA
Net Sales Rs m12,551146,302 8.6%  
Other income Rs m5422,287 23.7%   
Total revenues Rs m13,093148,589 8.8%   
Gross profit Rs m2,05524,758 8.3%  
Depreciation Rs m41213,229 3.1%   
Interest Rs m961,594 6.0%   
Profit before tax Rs m2,08812,222 17.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-70 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m4691,798 26.1%   
Profit after tax Rs m1,61910,354 15.6%  
Gross profit margin %16.416.9 96.7%  
Effective tax rate %22.514.7 152.7%   
Net profit margin %12.97.1 182.2%  
BALANCE SHEET DATA
Current assets Rs m7,77887,370 8.9%   
Current liabilities Rs m4,35833,081 13.2%   
Net working cap to sales %27.237.1 73.4%  
Current ratio x1.82.6 67.6%  
Inventory Days Days5587 62.9%  
Debtors Days Days8062 128.4%  
Net fixed assets Rs m5,713111,567 5.1%   
Share capital Rs m1701,609 10.5%   
"Free" reserves Rs m10,547123,645 8.5%   
Net worth Rs m10,937125,254 8.7%   
Long term debt Rs m036,454 0.0%   
Total assets Rs m15,574209,532 7.4%  
Interest coverage x22.88.7 263.3%   
Debt to equity ratio x00.3 0.0%  
Sales to assets ratio x0.80.7 115.4%   
Return on assets %11.05.7 193.0%  
Return on equity %14.88.3 179.0%  
Return on capital %20.08.5 234.9%  
Exports to sales %48.734.2 142.4%   
Imports to sales %7.18.3 84.9%   
Exports (fob) Rs m6,11550,050 12.2%   
Imports (cif) Rs m88912,203 7.3%   
Fx inflow Rs m6,16951,066 12.1%   
Fx outflow Rs m1,28517,678 7.3%   
Net fx Rs m4,88433,388 14.6%   
CASH FLOW
From Operations Rs m1,39723,824 5.9%  
From Investments Rs m-320-13,127 2.4%  
From Financial Activity Rs m-1,196-13,239 9.0%  
Net Cashflow Rs m-102-2,478 4.1%  

Share Holding

Indian Promoters % 55.4 16.0 346.3%  
Foreign collaborators % 0.3 20.8 1.4%  
Indian inst/Mut Fund % 3.4 12.2 27.8%  
FIIs % 3.9 23.7 16.5%  
ADR/GDR % 0.0 1.1 -  
Free float % 37.0 26.2 141.2%  
Shareholders   30,437 161,166 18.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   FULFORD INDIA  VENUS REMEDIES  IPCA LABS  CADILA HEALTHCARE  SUVEN LIFE  

Compare J.B.CHEMICALS With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Day up 260 Points; Pharma Stocks Top Gainers(Closing)

After opening the day in red, share markets in India witnessed positive trading activity throughout the day and ended the day on a positive note.

Related Views on News

CIPLA Announces Quarterly Results (4QFY18); Net Profit Down 347.8%

May 24, 2018 | Updated on May 24, 2018

For the quarter ended March 2018, CIPLA has posted a net profit of Rs 2 bn (down 347.8% YoY). Sales on the other hand came in at Rs 37 bn (up 3.2% YoY). Read on for a complete analysis of CIPLA's quarterly results.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Cipla: Extraordinary Income Boosts Net Profits (Quarterly Results Update - Detailed)

Oct 30, 2017

Proceeds from the sale of the South African animal business bolstered Cipla's net profits for the quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

More Views on News

Most Popular

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

Will You Dump Your Client if You're Busy? Inox Wind's Auditor Just Did...(The 5 Minute Wrapup)

Jun 14, 2018

After Inox Wind, you may see more auditors resigning And the reasons can be as funny as they can get.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Should You Invest In Mirae Asset Healthcare Fund?(Outside View)

Jun 15, 2018

Mirae Asset Mutual Fund launches NFO - Mirae Asset Helathcare Fund.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Jun 22, 2018 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS 5-YR ANALYSIS

COMPARE J.B.CHEMICALS WITH

MARKET STATS